Physician
Medical Practice Partners, LLC
Medical Practice Partners, LLC was paid $1.91M by Medicaid between Jan 2018 and Jul 2024, across 77 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 44% of everything it billed.
33Billing provider infoMEDICAL PRACTICE PARTNERS, LLC
BAY CITY, MI 48708
BAY CITY, MI 48708
33aNPI1144766965assigned 01/18/2017
33bProvider typeFamily Medicine Physician
28Total paid$1.91M
24GClaims129,486
24DCodes billed77
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Family Medicine Physician providers in Michigan
Rank by total paid#66 of 826
Median peer was paid$98K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,817 | $249K | |
| 2019 | 19,694 | $179K | |
| 2020 | 19,962 | $229K | |
| 2021 | 25,361 | $419K | |
| 2022 | 29,730 | $490K | |
| 2023 | 19,448 | $345K | |
| 2024incomplete | 474 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44% | 11,923 | 10,297 | $839K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 6,753 | 5,541 | $353K |
| 86328 | 5.7% | 3,618 | 2,925 | $109K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.6% | 3,679 | 2,959 | $88K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.4% | 2,985 | 2,480 | $84K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.1% | 8,868 | 6,973 | $78K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.0% | 417 | 417 | $39K |
| 90674 | 1.6% | 1,270 | 1,243 | $31K | |
| 99406 | 1.4% | 3,935 | 3,589 | $27K | |
| 20610 | 1.4% | 846 | 736 | $27K | |
| 20552 | 1.2% | 878 | 802 | $23K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 1,936 | 950 | $22K |
65 more codes
| 94010 | 1.1% | 1,372 | $21K | |
| 80305 | <1% | 4,572 | $18K | |
| 96160 | <1% | 983 | $15K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,488 | $13K |
| 93000 | <1% | 1,698 | $13K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 156 | $11K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 2,839 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 924 | $11K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,024 | $10K |
| 81002 | <1% | 4,566 | $9K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,358 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,144 | $8K |
| 80306 | <1% | 577 | $7K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,204 | $6K |
| 90756 | <1% | 288 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 885 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 48 | $3K |
| 0011A | <1% | 86 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 29 | $3K |
| 99386 | <1% | 15 | $2K | |
| 0012A | <1% | 49 | $2K | |
| 82948 | <1% | 397 | $2K | |
| 82962 | <1% | 834 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 27 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,286 | $1K |
| 36416 | <1% | 631 | $985.00 | |
| 99408 | <1% | 60 | $897.28 | |
| 0031A | <1% | 24 | $883.45 | |
| 69210 | <1% | 27 | $864.05 | |
| 82270 | <1% | 246 | $664.79 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 42 | $599.07 |
| 90658 | <1% | 53 | $579.42 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 47 | $358.26 |
| 97803 | <1% | 2,088 | $160.00 | |
| 97802 | <1% | 150 | $125.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14 | $3.74 |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 52 | $2.69 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 141 | $0.69 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 489 | $0.48 |
| 3074F | <1% | 8,210 | $0.10 | |
| 3079F | <1% | 6,905 | $0.07 | |
| 3078F | <1% | 4,017 | $0.07 | |
| 3075F | <1% | 2,756 | $0.04 | |
| 3008F | <1% | 1,673 | $0.03 | |
| 3080F | <1% | 455 | $0.01 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,102 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 2,574 | $0.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 560 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 1,579 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 107 | $0.00 |
| G8422 | Bmi not documented, documentation the patient is not eligible for bmi calculation | 0% | 55 | $0.00 |
| 94760 | 0% | 64 | $0.00 | |
| 4000F | 0% | 54 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 15 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 12 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 16 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 1,379 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 9,879 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 1,516 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 41 | $0.00 |
| 99173 | 0% | 52 | $0.00 | |
| 3077F | 0% | 372 | $0.00 | |
| 99497 | 0% | 17 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 39 | $0.00 |
| 3288F | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHAFER, RETA (BUSINESS MANAGER)